Baker Bros. Advisors LP Biocryst Pharmaceuticals Inc Transaction History

Baker Bros. Advisors LP

$9.34 Billion
Q3 2024

A detailed history of Baker Bros. Advisors LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Baker Bros. Advisors LP holds 75,778 shares of BCRX stock, worth $567,577. This represents 0.01% of its overall portfolio holdings.

Number of Shares

75,778

Previous 75,778 -0.0%

Holding current value

$567,577

Previous $468,000 22.86%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.13 - $6.79 $41.5 Million - $68.2 Million	-10,050,398 Reduced 99.25%	75,778 $468,000
Q4 2023 Feb 14, 2024	SELL	$4.98 - $6.77 $12.9 Million - $17.5 Million	-2,584,642 Reduced 20.33%	10,126,176 $60.7 Million
Q1 2021 May 17, 2021	BUY	$7.37 - $13.61 $110,550 - $204,150	15,000 Added 0.12%	12,710,818 $129 Million
Q3 2020 Nov 16, 2020	SELL	$3.43 - $5.53 $3.67 Million - $5.92 Million	-1,070,587 Reduced 7.78%	12,695,818 $43.6 Million
Q2 2020 Aug 14, 2020	BUY	$1.9 - $5.61 $5.36 Million - $15.8 Million	2,820,239 Added 25.76%	13,766,405 $65.6 Million
Q4 2019 Feb 14, 2020	SELL	$1.59 - $3.45 $2.83 Million - $6.14 Million	-1,779,306 Reduced 13.98%	10,946,166 $37.8 Million
Q3 2019 Nov 14, 2019	SELL	$2.5 - $3.73 $4.14 Million - $6.18 Million	-1,657,201 Reduced 11.52%	12,725,472 $36.5 Million
Q2 2019 Aug 14, 2019	SELL	$2.91 - $9.15 $2.14 Million - $6.73 Million	-735,408 Reduced 4.86%	14,382,673 $54.5 Million
Q1 2019 May 15, 2019	BUY	$7.38 - $9.72 $110,700 - $145,800	15,000 Added 0.1%	15,118,081 $123 Million
Q3 2018 Nov 14, 2018	BUY	$5.52 - $7.99 $6.02 Million - $8.72 Million	1,090,909 Added 7.79%	15,103,081 $115 Million
Q1 2018 May 15, 2018	BUY	$4.35 - $5.82 $65,249 - $87,300	15,000 Added 0.11%	14,012,172 $66.8 Million
Q3 2017 Nov 14, 2017	BUY	$4.1 - $5.97 $57.4 Million - $83.6 Million	13,997,172	13,997,172 $73.3 Million

Others Institutions Holding BCRX

# of Institutions

280

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.39B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Account

Baker Bros. Advisors LP Biocryst Pharmaceuticals Inc Transaction History